Intracellular interactions of umeclidinium and vilanterol in human airway smooth muscle
Nooreen Shaikh,1,2 Malcolm Johnson,3 David A Hall,4 Kian Fan Chung,1,2 John H Riley,3 Sally Worsley,5 Pankaj K Bhavsar1,2 1Experimental Studies, National Heart and Lung Institute, Imperial College London, 2Biomedical Research Unit, Royal Brompton and Harefield NHS Trust, London, 3Respiratory Global...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2017-06-01
|
| Series: | International Journal of COPD |
| Subjects: | |
| Online Access: | https://www.dovepress.com/intracellular-interactions-of-umeclidinium-and-vilanterol-in-human-air-peer-reviewed-article-COPD |
| _version_ | 1818683225890881536 |
|---|---|
| author | Shaikh N Johnson M Hall DA Chung KF Riley JH Worsley S Bhavsar PK |
| author_facet | Shaikh N Johnson M Hall DA Chung KF Riley JH Worsley S Bhavsar PK |
| author_sort | Shaikh N |
| collection | DOAJ |
| description | Nooreen Shaikh,1,2 Malcolm Johnson,3 David A Hall,4 Kian Fan Chung,1,2 John H Riley,3 Sally Worsley,5 Pankaj K Bhavsar1,2 1Experimental Studies, National Heart and Lung Institute, Imperial College London, 2Biomedical Research Unit, Royal Brompton and Harefield NHS Trust, London, 3Respiratory Global Franchise, GlaxoSmithKline, Uxbridge, 4Fibrosis and Lung Injury Development Planning Unit, GlaxoSmithKline, Stevenage, 5Respiratory Research & Development, GlaxoSmithKline, Uxbridge, UK Background: Intracellular mechanisms of action of umeclidinium (UMEC), a long-acting muscarinic receptor antagonist, and vilanterol (VI), a long-acting β2-adrenoceptor (β2R) agonist, were investigated in target cells: human airway smooth-muscle cells (ASMCs). Materials and methods: ASMCs from tracheas of healthy lung-transplant donors were treated with VI, UMEC, UMEC and VI combined, or control compounds (salmeterol, propranolol, ICI 118.551, or methacholine [MCh]). Cyclic adenosine monophosphate (cAMP) was measured using an enzyme-linked immunosorbent assay, intracellular free calcium ([Ca2+]i) using a fluorescence assay, and regulator of G-protein signaling 2 (RGS2) messenger RNA using real-time quantitative polymerase chain reaction. Results: VI and salmeterol (10–12–10–6 M) induced cAMP production from ASMCs in a concentration-dependent manner, which was greater for VI at all concentrations. β2R antagonism by propranolol or ICI 118.551 (10–12–10–4 M) resulted in concentration-dependent inhibition of VI-induced cAMP production, and ICI 118.551 was more potent. MCh (5×10–6 M, 30 minutes) attenuated VI-induced cAMP production (P<0.05), whereas pretreatment with UMEC (10–8 M, 1 hour) restored the magnitude of VI-induced cAMP production. ASMC stimulation with MCh (10–11–5×10–6 M) resulted in a concentration-dependent increase in [Ca2+]i, which was attenuated with UMEC pretreatment. Reduction of MCh-induced [Ca2+]i release was greater with UMEC + VI versus UMEC. UMEC enhanced VI-induced RGS2 messenger RNA expression. Conclusion: These data indicate that UMEC reverses cholinergic inhibition of VI-induced cAMP production, and is a more potent muscarinic receptor antagonist when in combination with VI versus either alone. Keywords: COPD pharmacology, cough/mechanisms/pharmacology, drug reactions |
| first_indexed | 2024-12-17T10:31:22Z |
| format | Article |
| id | doaj.art-71b78c024b5b40c3beed5035f2656d4b |
| institution | Directory Open Access Journal |
| issn | 1178-2005 |
| language | English |
| last_indexed | 2024-12-17T10:31:22Z |
| publishDate | 2017-06-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | International Journal of COPD |
| spelling | doaj.art-71b78c024b5b40c3beed5035f2656d4b2022-12-21T21:52:30ZengDove Medical PressInternational Journal of COPD1178-20052017-06-01Volume 121903191333549Intracellular interactions of umeclidinium and vilanterol in human airway smooth muscleShaikh NJohnson MHall DAChung KFRiley JHWorsley SBhavsar PKNooreen Shaikh,1,2 Malcolm Johnson,3 David A Hall,4 Kian Fan Chung,1,2 John H Riley,3 Sally Worsley,5 Pankaj K Bhavsar1,2 1Experimental Studies, National Heart and Lung Institute, Imperial College London, 2Biomedical Research Unit, Royal Brompton and Harefield NHS Trust, London, 3Respiratory Global Franchise, GlaxoSmithKline, Uxbridge, 4Fibrosis and Lung Injury Development Planning Unit, GlaxoSmithKline, Stevenage, 5Respiratory Research & Development, GlaxoSmithKline, Uxbridge, UK Background: Intracellular mechanisms of action of umeclidinium (UMEC), a long-acting muscarinic receptor antagonist, and vilanterol (VI), a long-acting β2-adrenoceptor (β2R) agonist, were investigated in target cells: human airway smooth-muscle cells (ASMCs). Materials and methods: ASMCs from tracheas of healthy lung-transplant donors were treated with VI, UMEC, UMEC and VI combined, or control compounds (salmeterol, propranolol, ICI 118.551, or methacholine [MCh]). Cyclic adenosine monophosphate (cAMP) was measured using an enzyme-linked immunosorbent assay, intracellular free calcium ([Ca2+]i) using a fluorescence assay, and regulator of G-protein signaling 2 (RGS2) messenger RNA using real-time quantitative polymerase chain reaction. Results: VI and salmeterol (10–12–10–6 M) induced cAMP production from ASMCs in a concentration-dependent manner, which was greater for VI at all concentrations. β2R antagonism by propranolol or ICI 118.551 (10–12–10–4 M) resulted in concentration-dependent inhibition of VI-induced cAMP production, and ICI 118.551 was more potent. MCh (5×10–6 M, 30 minutes) attenuated VI-induced cAMP production (P<0.05), whereas pretreatment with UMEC (10–8 M, 1 hour) restored the magnitude of VI-induced cAMP production. ASMC stimulation with MCh (10–11–5×10–6 M) resulted in a concentration-dependent increase in [Ca2+]i, which was attenuated with UMEC pretreatment. Reduction of MCh-induced [Ca2+]i release was greater with UMEC + VI versus UMEC. UMEC enhanced VI-induced RGS2 messenger RNA expression. Conclusion: These data indicate that UMEC reverses cholinergic inhibition of VI-induced cAMP production, and is a more potent muscarinic receptor antagonist when in combination with VI versus either alone. Keywords: COPD pharmacology, cough/mechanisms/pharmacology, drug reactionshttps://www.dovepress.com/intracellular-interactions-of-umeclidinium-and-vilanterol-in-human-air-peer-reviewed-article-COPDCOPD pharmacologyCough/Mechanisms/PharmacologyDrug reactions |
| spellingShingle | Shaikh N Johnson M Hall DA Chung KF Riley JH Worsley S Bhavsar PK Intracellular interactions of umeclidinium and vilanterol in human airway smooth muscle International Journal of COPD COPD pharmacology Cough/Mechanisms/Pharmacology Drug reactions |
| title | Intracellular interactions of umeclidinium and vilanterol in human airway smooth muscle |
| title_full | Intracellular interactions of umeclidinium and vilanterol in human airway smooth muscle |
| title_fullStr | Intracellular interactions of umeclidinium and vilanterol in human airway smooth muscle |
| title_full_unstemmed | Intracellular interactions of umeclidinium and vilanterol in human airway smooth muscle |
| title_short | Intracellular interactions of umeclidinium and vilanterol in human airway smooth muscle |
| title_sort | intracellular interactions of umeclidinium and vilanterol in human airway smooth muscle |
| topic | COPD pharmacology Cough/Mechanisms/Pharmacology Drug reactions |
| url | https://www.dovepress.com/intracellular-interactions-of-umeclidinium-and-vilanterol-in-human-air-peer-reviewed-article-COPD |
| work_keys_str_mv | AT shaikhn intracellularinteractionsofumeclidiniumandvilanterolinhumanairwaysmoothmuscle AT johnsonm intracellularinteractionsofumeclidiniumandvilanterolinhumanairwaysmoothmuscle AT hallda intracellularinteractionsofumeclidiniumandvilanterolinhumanairwaysmoothmuscle AT chungkf intracellularinteractionsofumeclidiniumandvilanterolinhumanairwaysmoothmuscle AT rileyjh intracellularinteractionsofumeclidiniumandvilanterolinhumanairwaysmoothmuscle AT worsleys intracellularinteractionsofumeclidiniumandvilanterolinhumanairwaysmoothmuscle AT bhavsarpk intracellularinteractionsofumeclidiniumandvilanterolinhumanairwaysmoothmuscle |